The Importance of Risk Stratification in a Structured Lung Nodule Program: An Expert Panel Discussion

Join Biodesix & the SAB on Tuesday, February 6th from 7:00p.m. – 8:00p.m EST. Hear from expert panelists Drs Jorge Mercado, Susan Garwood, & Luke Yuhico, as they explain conventional risk stratification methods and incorporation of biomarkers to optimize patient flow. They will discuss what the intended and unintended consequences of implementing a structured lung nodule program and what the value of systematic implementation of biomarker-based risk stratification. There will be a Q&A session after their lecture!